Subscribe to our Newsletters !!


    Dr Reddy’s’ settles case with Bristol Myers Squibb unit over nonexclusive malignant growth drug

    The Hyderabad-based firm has settled litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, Dr Reddy”s Laboratories said in a statement. In settlement of all outstanding claims in the litigation, Celgene has agreed to provide the company with a permit to sell volume-limited amounts of generic lenalidomide capsules in america starting on a confidential